Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2

Acta Biomaterialia

Volumn 6, Issue 7, 2010, Pages 2751-2759

  Tsurushima, Hideo ^a,b   Marushima, Aiki ^a   Suzuki, Kensuke ^a   Oyane, Ayako ^b   Sogo, Yu ^b   Nakamura, Kazuhiro ^a   Matsumura, Akira ^a   Ito, Atsuo ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Bone formation; Cranioplasty; Fibroblast growth factor 2; Hydroxyapatite ceramic button; Releasing drug delivery system

Indexed keywords

BIOACTIVITY; BONE; CALCIUM PHOSPHATE; CELL CULTURE; CERAMIC MATERIALS; CONTROLLED DRUG DELIVERY; FIBROBLASTS; HYDROXYAPATITE; TARGETED DRUG DELIVERY;

BONE FORMATION; BONE MORPHOGENIC PROTEIN; BONE SUBSTITUTES; CRANIOPLASTY; DRUG-DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR-2; HYDROXYAPATITE CERAMIC BUTTON; HYDROXYAPATITE CERAMICS; IN-VIVO; RELEASING DRUG DELIVERY SYSTEM;

RATS;

BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; FIBROBLAST GROWTH FACTOR 2; HYDROXYAPATITE; ALKALINE PHOSPHATASE; OSTEOCALCIN; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CELL PROLIFERATION; CERAMICS; CRANIOPLASTY; MALE; MATERIAL COATING; NONHUMAN; OSSIFICATION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; ANIMAL; BONE; BONE DEVELOPMENT; ENZYMOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

RATTUS;

ALKALINE PHOSPHATASE; ANIMALS; BASE SEQUENCE; BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; CERAMICS; DNA PRIMERS; FIBROBLAST GROWTH FACTOR 2; HYDROXYAPATITES; MICROSCOPY, ELECTRON, SCANNING; OSTEOCALCIN; POLYMERASE CHAIN REACTION; RATS;

EID: 77955872498     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.12.045     Document Type: Article

References (29)

1. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nagi H, Tagawa M, et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995;136:1276-84.
2. Rodan SB, Wesolowski G, Thomas KA, Yoon K, Rodan GA. Effect of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 1989;20:283-308.
3. Yamada K, Tabata Y, Yamamoto K, Miyamoto S, Nagata I, Kikuchi H, et al. Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 1997;86:871-5.
4. Hong L, Tabata Y, Miyamoto S, Yamamoto M, Yamada K, Hashimoto N, et al. Bone regeneration at rabbit skull defects treated with transforming growth factor-1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg 2000;92:315-25.
5. Kandziora F, Bail H, Schmidmaier G, Schollmeier G, Scholz M, Knispel C, et al. Bone morphogenetic protein-2 application by a poly (D, L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors. J Neurosurg (Spine 1) 2002;97:40-8.
6. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-62.
7. Sheehan JP, Sheehan JM, Seeherman H, Quigg M, Helm GA. The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. J Neurosurg 2003;98:125-30.
8. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
9. Illi OE, Feldmann CP. Stimulation of fracture healing by local application of humoral factors integrated in biodegradable implants. Eur J Pediatr Surg 1998;8:251-5.
10. Sogo Y, Ito A, Fukasawa K, Kondo N, Ishikawa Y, Ichinose N, et al. Coprecipitation of cytochrome C with calcium phosphate on hydroxyapatite ceramic. Curr Appl Phys 2005;5:526-30.
11. Sogo Y, Ito A, Onoguchi M, Oyane A, Tsurushima H, Ichinose N. Formation of FGF-2 and calcium phosphate composite layer for promoting bone formation on hydroxyapatite ceramic. Biomed Mater 2007;2: S175-80.
12. Pompili A, Caroli F, Carpanese L, Caterino M, Raus L, Sestili G, et al. Cranioplasty performed with a new osteoconductive, osteoinducing hydroxyapatitederived material. J Neurosurg 1998;89:236-42.
13. Sanan A, Haines SJ. Repairing holes in the head: a history of cranioplasty. J Neurosurg 1997;40:588-603.
14. Cuevas P, de Paz V, Cuevas B, Marin-Martinez J, Picon-Molina M, Fernandez-Pereira A, et al. Osteopromotion for cranioplasty: an experimental study in rats using acidic fibroblast growth factor. Surg Neurol 1997;47:242-6.
15. Aronin CEP, Sadik KW, Lay AL, Rion DB, Tholpady SS, Ogle RC, et al. Comparative effects of scaffold pore size, pore volume, and total void on cranial bone healing patterns using microsphere-based scaffolds. J Biomed Mater Res A 2009;89:632-41.
16. Ranieri AD, Virdi AS, Kuroda S, Shott S, Dai Y, Sumner DR. Local application of rhTGF-b2 modulates dynamic gene expression in a rat implant model. Bone 2005;36:931-40.
17. Choi KY, Kim HJ, Lee MH, Kwon TG, Nah HD, Furuichi T, et al. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 2005;233:115-21.
18. Fakhy A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stagedependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 2005;36:254-66.
19. Alam Md I, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 2001;22:1643-51.
20. Daculsi G, Pilet P, Cottrel M, Guicheux G. Role of fibronectin during biological apatite crystal nucleation: ultrastructural characterization. J Biomed Mater Res 1999;47:228-33.
21. Clark RAF. Synergistic signaling from extracellular matrix-growth factor complexes. J Invest Dermatol 2008;128:1354-5.
22. Schultz GS, Wyscoki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009;17:153-62.
23. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT. Age-related change in the biomolecular mechanisms of calvarial osteoblast biology affects fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem 2003;278:32005-13.
24. Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 2005;36:399-407.
25. Zellin G, Linde A. Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. Bone 2000;26:161-8.
26. Maus U, Andereya S, Ohnsorge JAK, Gravius S, Siebert CH, Niedhart C. A bFGF/TCP-composite inhibits bone formation in a sheep model. J Biomed Mater Res B Appl Biomater 2008;85:87-92.
27. Nakajima F, Nakajima A, Ogasawara A, Moriya H, Yamazaki M. Effects of a single percutaneous injection of basic fibroblast growth factor on the healing of a closed femoral shaft fracture in the rat. Calcif Tissue Int 2007;81:132-8.
28. Arnaud E. Advances in cranioplasty with osteoinductive biomaterials: summary of experimental studies and clinical prospects. Childs Nerv Syst 2000;16:659-68.
29. Josan VA, Sgouros S, Walsh AR, Dover MS, Nishikawa H, Hockley AD. Cranioplasty in children. Childs Nerv Syst 2005;21:200-4.